Spebrutinib (AVL-292)
Spebrutinib (AVL-292) is a covalent, orally active, and highly selective BTK inhibitor with IC50 of <0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1.
| Trivial name | CC-292 |
| Catalog Number | S7173 |
| CAS# | 1202757-89-8 |
| Size | 50mg |
| Supplier Page | http://www.selleckchem.com/products/avl-292.html |
| Additional Information | https://file.selleck.cn/downloads/struct/AVL-292-chemical-structure-s7173.gif |